A randomized, double-blind, vehicle-controlled study of VB-1953 in patients with moderate to severe acne

Trial Profile

A randomized, double-blind, vehicle-controlled study of VB-1953 in patients with moderate to severe acne

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs VB 1953 (Primary)
  • Indications Acne
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2017 New trial record
    • 24 Apr 2017 Results from this trial are expected later in 2017, according to a Vyome Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top